Net Cash Provided by (Used in) Operating Activities |
-1.44M |
USD |
+46.2% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
701K |
USD |
|
Q1 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
111K |
USD |
+1486% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q4 2024 |
FY 2024 |
Common Stock, Shares, Issued |
15.1M |
shares |
+6.88% |
Q4 2024 |
FY 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
3.18M |
USD |
-15.7% |
Q4 2024 |
FY 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
5K |
USD |
-37.5% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
100M |
USD |
-9.92% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
101M |
USD |
-10.2% |
Q4 2024 |
FY 2024 |
Property, Plant and Equipment, Gross |
508K |
USD |
0% |
Q4 2024 |
FY 2024 |
Operating Lease, Liability, Current |
18K |
USD |
-82.9% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
94.8M |
USD |
-9.71% |
Q4 2024 |
FY 2024 |
Current Income Tax Expense (Benefit) |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2024 |
Q3 2024 |
Depreciation, Depletion and Amortization |
495K |
USD |
+138% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
745K |
USD |
-37.1% |
Q4 2024 |
FY 2024 |
Share-based Payment Arrangement, Expense |
404K |
USD |
-0.25% |
Q4 2024 |
FY 2024 |